Suppression of Pathological Ocular Neovascularization by a Small Molecular Multi-Targeting Kinase Inhibitor, DCZ19903

PURPOSE: The administration of anti-vascular endothelial growth factor agents is the standard firs-line therapy for ocular vascular diseases, but some patients still have poor outcomes and drug resistance. This study investigated the role of DCZ19903, a small molecule multitarget kinase inhibitor, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Jingjuan, Li, Bo, Zhang, Huiying, Xu, Zhijian, Zhang, Qiuyang, Ye, Rong, Feng, Siguo, Jiang, Qin, Zhu, Weiliang, Yan, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2022
Materias:
Retina
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749868/
https://www.ncbi.nlm.nih.gov/pubmed/36484641
http://dx.doi.org/10.1167/tvst.11.12.8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749868/
https://www.ncbi.nlm.nih.gov/pubmed/36484641
http://dx.doi.org/10.1167/tvst.11.12.8

Ejemplares similares